4 Active Stocks on Traders' Radar Screens for 04/30/12: BMSN, BKS, GPRO, SEFE
April 30 2012 - 10:02AM
Marketwired
FinancialNewsMedia.com "stocks to watch" for today: Bio-Matrix
Scientific Group, Inc. (PINKSHEETS: BMSN), Barnes & Noble, Inc.
(NYSE: BKS), Gen-Probe Incorporated (NASDAQ: GPRO), SEFE, Inc.
(OTCBB: SEFE).
Breaking News Alert: Monday before the markets opened for
trading, Bio-Matrix Scientific Group, Inc. Announces Newly Formed
Stem Cell Subsidiary -- Regen BioPharma Inc., Secures $20,000,000
In Institutional Funding. Southridge Partners is to provide the $20
million in funding for the rapid commercialization of stem cell
therapies.
Regen BioPharma has developed a vertically-integrated structure
for acquiring patents, performing accelerating preclinical and
clinical development, and licensing or selling technology developed
to large pharma companies in the area of stem cells.
To date, Regen BioPharma has reviewed more than 20,000 US issued
patents covering stem cell related subject matter, created a
shortlist of 30 promising technologies for rapid commercialization,
and currently is in negotiations to license several of these. Once
the technology is secured, the Company anticipates partnering with
industry leading scientists, physicians, and service providers to
complete the Investigational New Drug (IND)-enabling work and begin
clinical trials.
"In biotechnology in general, and specifically in the area of
regenerative medicine, the biggest value creation occurs for
shareholders when a company files an IND and obtains human data
that provides proof of safety and efficacy," said David R. Koos,
Chairman and Chief Executive Officer of Bio-Matrix. "We are
assembling the team and capabilities to in-license and evaluate
technologies rapidly, then to develop the regulatory package and
initiate clinical trials. Our business model and partnerships will
allow us to take cell therapy products from discovery to FDA Phase
II clinical trials in as short a period as 18 - 24 months."
Read the entire BMSN press release announcing Bio-Matrix
Scientific Group's new subsidiary, Regen BioPharma, Inc. along with
their full disclosure here:
http://www.financialnewsmedia.com/stock-investing-business-investing-news/featured-news.php?id=148
Get an edge on the market with our Premium News
Alerts that are FREE for a limited time at
http://www.financialnewsmedia.com. Follow us on Facebook:
http://www.facebook.com/financialnewsmedia and Twitter:
http://twitter.com/FNMgroup
Barnes & Noble, Inc. (NYSE: BKS) announced that Microsoft
will make a $300 million investment in a new Barnes & Noble
subsidiary. BKS is up over 90% and 3.4Mill shares traded so far in
pre-market trading. (4/30/12).
Gen-Probe Incorporated (NASDAQ: GPRO) announced this morning
before the markets open that Hologic, Inc. will acquire all the
outstanding shares of Gen-Probe for $82.75 per share in cash, or a
total enterprise value of approximately $3.7 billion. GPRO is up
over 19% and 1.8Mill shares traded so far in pre-market trading.
(4/30/12).
SEFE, Inc. (OTCBB: SEFE) introduced a summary of its tether
contact system and its role in the company's flagship Harmony III
product. SEFE was up over 4% in early trading on when the markets
opened this morning. (04/30/12)
If you're a company interested in having FN
Media Group assist you with creating a greater awareness for your
next news release utilizing our multi-media and leading edge
outreach solutions, contact us now at
info@financialnewsmedia.com
DISCLAIMER: FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM) which disseminates electronic
information through multiple online media channels. FNMG's intended
purposes are to deliver market updates and news alerts issued from
private and publicly trading companies as well as providing
coverage and increased awareness for companies that issue press to
the public via online newswires. FNMG and its affiliated companies
are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to sell or offer to buy
any security. FNMG's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. An offer to buy or sell can be made only with
accompanying disclosure documents from the company offering or
selling securities and only in the states and provinces for which
they are approved. The material in this release is
intended to be strictly informational and is NEVER to be construed
or interpreted as research material. All readers are strongly
urged to perform research and due diligence on their own and
consult a licensed financial professional before considering any
level of investing in stocks. The companies that are discussed in
this release may or may not have approved the statements made in
this release. Information in this release is derived from a variety
of sources that may or may not include the referenced company's
publicly disseminated information. The accuracy or completeness of
the information is not warranted and is only as reliable as the
sources from which it was obtained. While this information is
believed to be reliable, such reliability cannot be guaranteed.
FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material
fact in this release. This release may contain technical
inaccuracies or typographical errors. It is strongly recommended
that any purchase or sale decision be discussed with a financial
adviser, or a broker-dealer, or a member of any financial
regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high
degree of risk. FNMG is not liable for any investment decisions by
its readers or subscribers. Investors are cautioned that they may
lose all or a portion of their investment when investing in
stocks.
This release is not without bias, and is considered a conflict
of interest if compensation has been received by FNMG for its
dissemination. To comply with Section 17(b) of the Securities Act
of 1933, FNMG shall always disclose any compensation it has
received, or expects to receive in the future, for the
dissemination of the information found herein on behalf of one or
more of the companies mentioned in this release. For disseminating
this release, FNMG expects to be compensated by a non-affiliated
third party five thousand dollars per week for continued coverage
of Bio-Matrix Scientific Group, Inc (PINKSHEETS: BMSN) News.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS
RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and FNMG undertakes no
obligation to update such statements.
Contact Information: Contact email: Email Contact URL:
http://www.financialnewsmedia.com Company:
FinancialNewsMedia.com
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jun 2024 to Jul 2024
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jul 2023 to Jul 2024